Low- dose systemic steroids, an emerging therapeutic option for COVID-19 related urticaria.
J Dermatolog Treat
; 33(2): 1140-1141, 2022 Mar.
Article
in English
| MEDLINE | ID: covidwho-639607
ABSTRACT
Dermatologists around the world are still doing their best to report more cutaneous manifestations of the emerging COVID-19 infection. New-onset acute or relapsing chronic urticaria may result from the body's overreacting inflammatory response to infection. The cytokine storm hits different organs in the body, including the skin, leading to activation and degranulation of mast cells with resultant urticaria. Low-dose systemic steroids combined with antihistamines can combat the COVID-19 inflammatory insult and play a role in the control of COVID-19 related severe urticarial attack.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Urticaria
/
Chronic Urticaria
/
COVID-19
Topics:
Long Covid
Limits:
Humans
Language:
English
Journal:
J Dermatolog Treat
Journal subject:
Dermatology
Year:
2022
Document Type:
Article
Affiliation country:
09546634.2020.1795062
Similar
MEDLINE
...
LILACS
LIS